Nearly half (47%) of the global population has limited or no access to key tests and services that are essential for diagnosing common diseases, such as diabetes, hypertension, HIV, and tuberculosis, or basic tests for pregnant ...
Oct 6, 2021
0
7
Minority populations in the US with multiple sclerosis and other autoimmune diseases experience poorer outcomes due to modifiable social conditions, according to a new USC study. Social determinants of health (SDOH) – ...
Oct 4, 2021
0
0
In a study of the 9 largest U.S. cities, researchers at Columbia University Mailman School of Public Health found stark racial, ethnic, and socioeconomic inequities in COVID-19 vaccination rates across neighborhoods. The ...
Sep 8, 2021
0
27
More than five billion anti-COVID jabs have been given globally, but wide disparities between rich and poor countries in access to vaccines persist.
Aug 24, 2021
0
381
The most powerful tool for combating COVID is not a drug or a vaccine, but a method. A randomized trial is the best way to discover what works and what doesn't. This method underlies much of the progress in modern medicine, ...
Aug 23, 2021
0
5
CanStaging⁺, a user-friendly tool aimed at facilitating the recording of comparable cancer staging data worldwide, has been launched.
Aug 2, 2021
0
0
Although more than four billion doses of anti-COVID vaccines have been administered around the world, poorer countries are still struggling to secure precious shots despite recent donations.
Jul 29, 2021
0
3
In the race between infection and injection, injection has lost.
Jun 23, 2021
0
0
People who experience very severe COVID-19 illness have a higher prevalence of persistent symptoms, according to a new University of Michigan study.
May 18, 2021
0
6
In 2003 in Haiti, a 20-year-old in treatment for HIV could have expected to live to 34. But as of 2017, life expectancy for a 20-year-old in treatment for HIV in Haiti is now 61, compared to 70 for Haiti's general population.
Apr 20, 2021
0
4
